IGC
India Globalization Capital Inc
AMEX: IGC · HEALTHCARE · BIOTECHNOLOGY
$0.30
+3.45% today
Updated 2026-06-03
Market cap
$28.63M
P/E ratio
—
P/S ratio
25.88x
EPS (TTM)
$-0.06
Dividend yield
—
52W range
$0 – $1
Volume
1.4M
India Globalization Capital Inc (IGC) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$0.30
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$2.50
Financial forecast
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.